TRADING QUOTES        CLICK ON A TAB BELOW: (Business Combination or IPO Details) to access the relevant details.  Additional info below.  PROPOSED BUSINESS COMBINATION: Immatics Biotherapeutics GmbH ESTIMATED CURRENT FUNDS in TRUST: $148.7 million*CURRENT PER SHARE REDEMPTION PRICE: $10.35*ENTERPRISE VALUE: $314.8 million *SPACInsider estimate a/o 6-28-20 Arya Sciences Acquisition Corp. proposes to combine
Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.